1. Home
  2. ENOV vs WLDN Comparison

ENOV vs WLDN Comparison

Compare ENOV & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • WLDN
  • Stock Information
  • Founded
  • ENOV 1995
  • WLDN 1964
  • Country
  • ENOV United States
  • WLDN United States
  • Employees
  • ENOV N/A
  • WLDN N/A
  • Industry
  • ENOV Fluid Controls
  • WLDN Military/Government/Technical
  • Sector
  • ENOV Industrials
  • WLDN Consumer Discretionary
  • Exchange
  • ENOV Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • ENOV 1.6B
  • WLDN 1.6B
  • IPO Year
  • ENOV 2008
  • WLDN 2006
  • Fundamental
  • Price
  • ENOV $32.14
  • WLDN $98.86
  • Analyst Decision
  • ENOV Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • ENOV 6
  • WLDN 2
  • Target Price
  • ENOV $51.00
  • WLDN $111.50
  • AVG Volume (30 Days)
  • ENOV 1.0M
  • WLDN 557.6K
  • Earning Date
  • ENOV 11-05-2025
  • WLDN 10-30-2025
  • Dividend Yield
  • ENOV N/A
  • WLDN N/A
  • EPS Growth
  • ENOV N/A
  • WLDN 94.22
  • EPS
  • ENOV N/A
  • WLDN 2.39
  • Revenue
  • ENOV $2,189,576,000.00
  • WLDN $628,172,000.00
  • Revenue This Year
  • ENOV $9.13
  • WLDN N/A
  • Revenue Next Year
  • ENOV $6.39
  • WLDN $9.00
  • P/E Ratio
  • ENOV N/A
  • WLDN $41.28
  • Revenue Growth
  • ENOV 14.40
  • WLDN 13.82
  • 52 Week Low
  • ENOV $25.47
  • WLDN $30.43
  • 52 Week High
  • ENOV $49.83
  • WLDN $121.00
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 62.91
  • WLDN 45.24
  • Support Level
  • ENOV $30.00
  • WLDN $113.07
  • Resistance Level
  • ENOV $31.76
  • WLDN $118.00
  • Average True Range (ATR)
  • ENOV 1.04
  • WLDN 5.50
  • MACD
  • ENOV 0.21
  • WLDN -2.79
  • Stochastic Oscillator
  • ENOV 82.68
  • WLDN 12.58

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: